healthcare · LALPATHLAB
Dr. Lal Pathlabs
Dr. Lal Pathlabs: PE above historical average. NARROW LEADERSHIP regime.
Price
₹1,878.8
Price 2026-07-30
5 day
+7.08%
Short-term move
1 month
+14.13%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹28.1k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Dr. Lal Pathlabs (LALPATHLAB) in the healthcare sector?”
Price chart
₹1,800
+29.63% over period
About Dr. Lal Pathlabs
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -8.6% over 14 days) — not a reliable pattern.
52-week position
Trading at 104.2% of 52-week high
Technicals
RSI 14
73.9
Trend
uptrend
50 DMA
Above
200 DMA
Above
Key metrics
P/E ratio
55.7
67th pct · 9 quarterly points (~2.2y)
P/B
11.2
ROE
21.5%
Strong profitability — 21.5% return on equity
Market cap
₹28.1k Cr
Revenue growth
1660.0% YoY
Promoter
54.9%
52-week range
₹1,272.6 – ₹1,803
104.2% of high
RSI (14)
73.9
uptrend
vs 50 DMA
Above
DMA ₹1,665.83
Coverage
100/100
HIGH
Quick Take
Dr. Lal Pathlabs: PE above historical average. NARROW LEADERSHIP regime.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
Tensions to watch
Promoter holding at 54.9% — neither distress selling nor aggressive buying
No strong insider signal. Watch for changes in promoter stake as a leading indicator.
Key Watchpoints
Breaks above ₹1973 (+5%)
Trend reversal confirmation
Breaks below ₹1785 (-5%)
Further downside risk
PE reverts to median of 52.1 (9 quarterly points (~2.2y))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal
